IPIX (Innovation Pharmaceuticals) Insider Ownership: 10.55 % (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Innovation Pharmaceuticals Insider Ownership?

Innovation Pharmaceuticals IPIX Insider Ownership is 10.55 % as of Jul. 19, 2026.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Innovation Pharmaceuticals's insider ownership is 10.55%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Innovation Pharmaceuticals's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Innovation Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 98.31%.

Innovation Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Insider Ownership Chart

Innovation Pharmaceuticals Historical Data

The historical data trend for Innovation Pharmaceuticals can be seen below:

2018-02-28 2018-03-31 2018-04-30 2018-05-31 2018-06-30 2018-07-31 2018-08-31 2018-09-30 2018-10-31 2018-11-30
Insider Ownership 10.55 10.55 10.55 10.55 10.55 10.55 10.55 10.55 10.55 10.55

Innovation Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 10.55 % mean?
Innovation Pharmaceuticals (IPIX) has a Insider Ownership of 10.55 % as of Jul. 19, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Innovation Pharmaceuticals and its competitors.
Is Innovation Pharmaceuticals' Insider Ownership too high?
Innovation Pharmaceuticals' current Insider Ownership is 10.55 %.
How does Innovation Pharmaceuticals' Insider Ownership compare to AXIM and RNAZ?
Innovation Pharmaceuticals' Insider Ownership of 10.55 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Innovation Pharmaceuticals and its competitors. Innovation Pharmaceuticals's current Insider Ownership is 10.55 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation Pharmaceuticals stock overvalued right now?
Innovation Pharmaceuticals (IPIX) has a current Insider Ownership of 10.55 %. The current Insider Ownership is 10.55 %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current Insider Ownership is 10.55 % as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.